- Home
- WMS vs HALO Comparison
WMS vs HALO Comparison
Compare WMS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMS
- HALO
- Stock Information
- Founded
- WMS 1966
- HALO 1998
- Country
- WMS United States
- HALO United States
- Employees
- WMS N/A
- HALO N/A
- Industry
- WMS Containers/Packaging
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WMS Consumer Discretionary
- HALO Health Care
- Exchange
- WMS Nasdaq
- HALO Nasdaq
- Market Cap
- WMS 8.6B
- HALO 7.4B
- IPO Year
- WMS 2014
- HALO N/A
- Fundamental
- Price
- WMS $104.39
- HALO $58.79
- Analyst Decision
- WMS Strong Buy
- HALO Buy
- Analyst Count
- WMS 9
- HALO 9
- Target Price
- WMS $153.78
- HALO $61.63
- AVG Volume (30 Days)
- WMS 666.8K
- HALO 1.8M
- Earning Date
- WMS 05-15-2025
- HALO 05-06-2025
- Dividend Yield
- WMS 0.61%
- HALO N/A
- EPS Growth
- WMS N/A
- HALO 63.33
- EPS
- WMS 5.98
- HALO 3.43
- Revenue
- WMS $2,942,324,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- WMS $3.53
- HALO $20.06
- Revenue Next Year
- WMS $4.77
- HALO $24.04
- P/E Ratio
- WMS $17.47
- HALO $17.14
- Revenue Growth
- WMS 3.67
- HALO 22.44
- 52 Week Low
- WMS $93.92
- HALO $37.73
- 52 Week High
- WMS $184.27
- HALO $66.00
- Technical
- Relative Strength Index (RSI)
- WMS 45.28
- HALO 44.06
- Support Level
- WMS $102.12
- HALO $57.50
- Resistance Level
- WMS $107.68
- HALO $62.14
- Average True Range (ATR)
- WMS 5.59
- HALO 2.90
- MACD
- WMS 0.26
- HALO -0.40
- Stochastic Oscillator
- WMS 64.80
- HALO 36.41
About WMS Advanced Drainage Systems Inc.
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe; Infiltrator; International and Allied Products and Other. It generates maximum revenue from the Pipe segment. The company serves Agriculture; Aviation and Military; Mining; Residential; Transportation; Healthcare and Education and others.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.